4 completed, 2 withdrawn, 1 terminated. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Withdrawn 2, Terminated 1 |
Follow CytRx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer Tamibarotene, Placebo - Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer | Phase 2 | Terminated | CytRx | 140 | 2011-04-01 | 2013-06-28 |
| Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer Bafetinib - Hormone Refractory Prostate Cancer | Phase 2 | Completed | CytRx | 23 | 2010-08-01 | 2011-12-15 |
| Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) bafetinib - B-Cell Chronic Lymphocytic Leukemia | Phase 2 | Completed | CytRx | 20 | 2010-06-01 | 2013-05-15 |
| INNO-206 in Patients With Small Cell Lung Cancer (SCLC) INNO-206 - Small Cell Lung Cancer | Phase 2 | Withdrawn | CytRx | 2008-05-01 | 2012-02-09 | |
| Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL Tamibarotene - Acute Promyelocytic Leukemia | Phase 2 | Completed | CytRx | 15 | 2007-09-01 | 2013-02-13 |
| A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS arimoclomol - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Completed | CytRx | 80 | 2005-10-01 | 2012-02-09 |
| A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS Placebo, Arimoclomol - Amyotrophic Lateral Sclerosis | Phase 2 | Withdrawn | CytRx | 2012-02-09 |
Amyotrophic Lateral Sclerosis (2) · Carcinoma, Non-Small-Cell Lung (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Promyelocytic, Acute (1) · Small Cell Lung Carcinoma (1)
arimoclomol (2) · bafetinib (2) · tamibarotene (2) · DOXO-EMCH (1)
United States (7) · Bulgaria (1) · Canada (1) · India (1) · Mexico (1) · Russia (1) · Ukraine (1)
Daniel Levitt, M.D., Ph.D. (2) · Jeremy Shefner, MD (1) · Jeremy Shefner, MD, PhD (1) · Jorge Cortes, MD (1) · Merit Cudkowicz, MD (1) · Merit Cudkowicz, MD, MSc (1) · Michael Maitland, MD (1) · Oscar Arrieta, M.D. (1)